Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study.

J Clin Psychopharmacol

Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA Department of Psychology, Barnard College and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY Department of Psychiatry and Behavioral Sciences, Stanford

Published: February 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326118PMC
http://dx.doi.org/10.1097/JCP.0000000000000994DOI Listing

Publication Analysis

Top Keywords

exploring brain-derived
4
brain-derived neurotrophic
4
neurotrophic factor
4
factor val66met
4
val66met polymorphism
4
polymorphism extinction
4
extinction learning-based
4
learning-based treatment
4
treatment outcome
4
outcome obsessive-compulsive
4

Similar Publications

The ketogenic diet (KD), a high-fat, low-carbohydrate regimen, has been shown to exert neuroprotective effects in various neurological models. This study explored how KD-alone or combined with antibiotic-induced gut microbiota depletion-affects cognition and neuroinflammation in aging. Thirty-two male rats (22 months old) were assigned to four groups (n = 8): control diet (CD), ketogenic diet (KD), antibiotics with control diet (AB), and antibiotics with KD (KDAB).

View Article and Find Full Text PDF

This study explored the effects of Jiuwei Zhenxin (JWZX) granules on serum triggering receptor expressed on myeloid cells 1 (TREM1) levels and their role in regulating depression and anxiety in patients with coronary heart disease (CHD). A total of 100 CHD patients were enrolled from January 2020 to January 2023: 50 received JWZX granules and 50 underwent conventional treatment. Clinical data and psychological scores were collected.

View Article and Find Full Text PDF

Magnetic Targeting of AAV Gene Therapy for Inner Ear Following Systemic Delivery: Preliminary Findings and Transduction Pattern in Rat Cochlea.

J Assoc Res Otolaryngol

September 2025

Biological Sciences Platform, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room M1 102, Toronto, ON, M4N 3M5, Canada.

Purpose: Delivery of therapeutics to the inner ear is complicated by their inaccessible location and the presence of the blood-labyrinth barrier that restricts most blood-borne compounds from entering the inner ear. This study addresses the challenge of optimal delivery in treating inner ear disease, focusing on magnetic targeting gene therapy using adeno-associated virus (AAV).

Methods: The investigation explores three AAV serotypes (AAV2 Quad Mut, AAV2 pANC80L65, and AAV9 PHP.

View Article and Find Full Text PDF

Introduction: The development of new drugs for Alzheimer's disease (AD) remains a major challenge due to the disorder's complex and multifactorial nature. 2'-Fucosyllactose (2'-FL), a human milk oligosaccharide, has demonstrated promising neuroprotective properties. However, its effects on AD-related cognitive decline are not yet fully understood.

View Article and Find Full Text PDF

Fatigue is a prevalent and debilitating symptom in rheumatic diseases such as rheumatoid arthritis and psoriatic arthritis. Despite advances in reducing inflammation through treatments, fatigue often persists, underscoring its multifactorial etiology. A possible link between the persistent inflammation observed in rheumatic diseases and the onset of fatigue has been suggested.

View Article and Find Full Text PDF